| molecular function |
|---|
| | GO:0005096 | | GTPase activator activity | | Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP. |
| | GO:0070411 | | I-SMAD binding | | Interacting selectively and non-covalently with an inhibitory SMAD signaling protein. |
| | GO:0046332 | | SMAD binding | | Interacting selectively and non-covalently with a SMAD signaling protein. |
| | GO:0070016 | | armadillo repeat domain binding | | Interacting selectively and non-covalently with the armadillo repeat domain of a protein, an approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity protein armadillo. Arm-repeat proteins are involved in various processes, including intracellular signalling and cytoskeletal regulation. |
| | GO:0008013 | | beta-catenin binding | | Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
| | GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0032947 | | protein complex scaffold activity | | A structural molecule activity that provides a physical support for the assembly of a multiprotein complex. The scaffold may or may not be part of the final complex. |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| | GO:0030159 | | receptor signaling complex scaffold activity | | Functions to provide a physical support for the assembly of a multiprotein receptor signaling complex. |
| | GO:0004871 | | signal transducer activity | | Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response. |
| | GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| biological process |
|---|
| | GO:0016055 | | Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
| | GO:0090244 | | Wnt signaling pathway involved in somitogenesis | | The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state that contributes to somitogenesis. |
| | GO:0021881 | | Wnt-activated signaling pathway involved in forebrain neuron fate commitment | | The series of molecular signals initiated by binding of Wnt protein to a receptor on the surface of the target cell that contributes to the commitment of a neuroblast to aneuronal fate. The neuron will reside in the forebrain. |
| | GO:0007257 | | activation of JUN kinase activity | | The initiation of the activity of the inactive enzyme JUN kinase (JNK). |
| | GO:0032147 | | activation of protein kinase activity | | Any process that initiates the activity of an inactive protein kinase. |
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0048320 | | axial mesoderm formation | | The process that gives rise to the axial mesoderm. This process pertains to the initial formation of the structure from unspecified parts. |
| | GO:1904885 | | beta-catenin destruction complex assembly | | The aggregation, arrangement and bonding together of a set of components to form a beta-catenin destruction complex. |
| | GO:1904886 | | beta-catenin destruction complex disassembly | | The disaggregation of a beta-catenin destruction complex into its constituent components. |
| | GO:0060070 | | canonical Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
| | GO:0060823 | | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contributes to the formation of the neural plate anterior/posterior pattern. |
| | GO:0008219 | | cell death | | Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538). |
| | GO:0043623 | | cellular protein complex assembly | | The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell. |
| | GO:0071407 | | cellular response to organic cyclic compound | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| | GO:0031122 | | cytoplasmic microtubule organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures formed of microtubules and associated proteins in the cytoplasm of a cell. |
| | GO:0007368 | | determination of left/right symmetry | | The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry. |
| | GO:0009950 | | dorsal/ventral axis specification | | The establishment, maintenance and elaboration of the dorsal/ventral axis. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism. |
| | GO:0048048 | | embryonic eye morphogenesis | | The process occurring in the embryo by which the anatomical structures of the post-embryonic eye are generated and organized. |
| | GO:0060272 | | embryonic skeletal joint morphogenesis | | The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton. |
| | GO:0021797 | | forebrain anterior/posterior pattern specification | | The creation of specific areas of progenitor domains along the anterior-posterior axis of the developing forebrain. |
| | GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| | GO:0055001 | | muscle cell development | | The process whose specific outcome is the progression of a muscle cell over time, from its formation to the mature structure. Muscle cell development does not include the steps involved in committing an unspecified cell to the muscle cell fate. |
| | GO:0030178 | | negative regulation of Wnt signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway. |
| | GO:0090090 | | negative regulation of canonical Wnt signaling pathway | | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| | GO:0045599 | | negative regulation of fat cell differentiation | | Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation. |
| | GO:0034244 | | negative regulation of transcription elongation from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II. |
| | GO:0030910 | | olfactory placode formation | | The formation of a thickening of the neural ectoderm in the head region of the vertebrate embryo which develops into the olfactory region of the nasal cavity. |
| | GO:0001743 | | optic placode formation | | The initial developmental process that will lead to the formation of an eye. |
| | GO:0043547 | | positive regulation of GTPase activity | | Any process that activates or increases the activity of a GTPase. |
| | GO:0046330 | | positive regulation of JNK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
| | GO:0090263 | | positive regulation of canonical Wnt signaling pathway | | Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| | GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| | GO:0010800 | | positive regulation of peptidyl-threonine phosphorylation | | Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
| | GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| | GO:0001934 | | positive regulation of protein phosphorylation | | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| | GO:0031398 | | positive regulation of protein ubiquitination | | Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| | GO:2000060 | | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | | Any process that activates or increases the frequency, rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0051443 | | positive regulation of ubiquitin-protein transferase activity | | Any process that activates, maintains or increases the rate of ubiquitin transferase activity. |
| | GO:0043161 | | proteasome-mediated ubiquitin-dependent protein catabolic process | | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| | GO:0035412 | | regulation of catenin import into nucleus | | Any process that modulates the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus. |
| | GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| cellular component |
|---|
| | GO:0030877 | | beta-catenin destruction complex | | A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome. |
| | GO:0005938 | | cell cortex | | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
| | GO:0071944 | | cell periphery | | The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005881 | | cytoplasmic microtubule | | Any microtubule in the cytoplasm of a cell. |
| | GO:0031410 | | cytoplasmic vesicle | | A vesicle found in the cytoplasm of a cell. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0016328 | | lateral plasma membrane | | The portion of the plasma membrane at the lateral side of the cell. In epithelial cells, lateral plasma membranes are on the sides of cells which lie at the interface of adjacent cells. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0014069 | | postsynaptic density of dendrite | | An electron dense network of proteins within and adjacent to the postsynaptic membrane of the dendrite of asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. |
Description
